The store will not work correctly when cookies are disabled.
(-)-R-1-(1-(5-chlorothiophen-3-yl)-2-(4-methylpiperazin-1-yl)ethyl)cyclohexanol
ID: ALA1099178
PubChem CID: 11210071
Max Phase: Preclinical
Molecular Formula: C17H27ClN2OS
Molecular Weight: 342.94
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CN1CCN(C[C@@H](c2csc(Cl)c2)C2(O)CCCCC2)CC1
Standard InChI: InChI=1S/C17H27ClN2OS/c1-19-7-9-20(10-8-19)12-15(14-11-16(18)22-13-14)17(21)5-3-2-4-6-17/h11,13,15,21H,2-10,12H2,1H3/t15-/m0/s1
Standard InChI Key: KHYNNQYNYMSTIB-HNNXBMFYSA-N
Molfile:
RDKit 2D
22 24 0 0 0 0 0 0 0 0999 V2000
-1.0775 -1.6697 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-1.4917 -0.9589 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9332 -0.3364 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.1892 -0.6702 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2743 -1.4883 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3121 -0.8752 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
0.5254 -0.2577 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.6181 1.8045 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.6174 0.9793 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9030 0.5686 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.1888 0.9795 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.1890 1.8054 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9033 2.2201 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5254 0.5672 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2392 -0.6698 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7075 -1.3008 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9876 -2.0764 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8000 -2.2201 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3323 -1.5876 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0522 -0.8113 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5200 0.1050 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.3323 2.2168 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8 13 1 0
9 10 1 0
10 11 1 0
11 12 1 0
12 13 1 0
11 14 1 0
7 14 1 6
7 15 1 0
15 16 1 0
4 7 1 0
8 9 1 0
1 2 1 0
2 3 2 0
3 4 1 0
15 20 1 0
16 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
4 5 2 0
15 21 1 0
5 1 1 0
8 22 1 0
2 6 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 342.94 | Molecular Weight (Monoisotopic): 342.1533 | AlogP: 3.43 | #Rotatable Bonds: 4 |
Polar Surface Area: 26.71 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 7.75 | CX LogP: 3.29 | CX LogD: 2.78 |
Aromatic Rings: 1 | Heavy Atoms: 22 | QED Weighted: 0.91 | Np Likeness Score: -0.49 |
References
1. Sabatucci JP, Mahaney PE, Leiter J, Johnston G, Burroughs K, Cosmi S, Zhang Y, Ho D, Deecher DC, Trybulski E.. (2010) Heterocyclic cycloalkanol ethylamines as norepinephrine reuptake inhibitors., 20 (9): [PMID:20378347] [10.1016/j.bmcl.2010.03.059] |